Literature DB >> 1634441

5,8,11,14-eicosatetraynoic acid-induced destruction of mitochondria in human prostate cells (PC-3).

K M Anderson1, T M Seed, D E Wilson, J E Harris.   

Abstract

Culturing human prostate PC-3 cells for 4, 24, or 72 h in the presence of 5,8,11,14-eicosatetraynoic acid (ETYA), an inhibitor of arachidonic acid metabolism and cholesterol biosynthesis, markedly altered the morphology and reduced the number of mitochondria in the treated cells. Using quantitative electron microscopic morphometry, we documented changes in the number, form, area, matrix density, and integrity of the cristae and limiting membranes of mitochondria in cells cultured with ETYA. The inhibition of cholesterol synthesis or the substitution of ETYA for polyunsaturated fatty acids in the inner membrane may participate in the disruption of the mitochondria, which resembles the morphologic sequelae of oxidative stress. If sufficiently extensive, these changes could contribute to the inhibition of cellular proliferation by ETYA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634441     DOI: 10.1007/bf02634044

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  18 in total

1.  Ultrastructural evidence for differentiation in a human glioblastoma cell line treated with inhibitors of eicosanoid metabolism.

Authors:  D E Wilson; K M Anderson; T M Seed
Journal:  Neurosurgery       Date:  1990-10       Impact factor: 4.654

Review 2.  Tumor mitochondria and the bioenergetics of cancer cells.

Authors:  P L Pedersen
Journal:  Prog Exp Tumor Res       Date:  1978

3.  Distribution of membrane-confined phospholipases A in the rat hepatocyte.

Authors:  J Nachbaur; A Colbeau; P M Vignais
Journal:  Biochim Biophys Acta       Date:  1972-08-09

4.  Tumor cell mitochondrial matrix/cristae complexes as potential sites for anticancer therapy with polyunsaturated fatty acid analogues.

Authors:  K M Anderson; T Seed; F Ondrey; D Wilson; J E Harris
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1990-06       Impact factor: 4.006

Review 5.  The effect of 5,8,11,14-eicosatetraynoic acid on lipid metabolism.

Authors:  L D Tobias; J G Hamilton
Journal:  Lipids       Date:  1979-02       Impact factor: 1.880

6.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

Authors:  M E Kaighn; K S Narayan; Y Ohnuki; J F Lechner; L W Jones
Journal:  Invest Urol       Date:  1979-07

Review 7.  Lipid peroxidation in tumour cells.

Authors:  L Masotti; E Casali; T Galeotti
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

8.  Incorporation of 5,8,11,14-eicosatetraynoic acid (ETYA) into cell lipids: competition with arachidonic acid for esterification.

Authors:  A S Taylor; A R Morrison; J H Russell
Journal:  Prostaglandins       Date:  1985-03

9.  Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4.

Authors:  F Ondrey; J E Harris; K M Anderson
Journal:  Cancer Res       Date:  1989-03-01       Impact factor: 12.701

10.  Human PC-3 prostate cell line DNA synthesis is suppressed by eicosatetraynoic acid, an in vitro inhibitor of arachidonic acid metabolism.

Authors:  K M Anderson; J B Wygodny; F Ondrey; J Harris
Journal:  Prostate       Date:  1988       Impact factor: 4.104

View more
  1 in total

1.  Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.

Authors:  Jiazhong Jiang; Blake Lee Neubauer; Jeremy R Graff; Marcio Chedid; James E Thomas; Neal W Roehm; Shaobo Zhang; George J Eckert; Michael O Koch; John N Eble; Liang Cheng
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.